Fluphenazine decanoate injections – supply and reimbursement update

Fluphenazine decanoate injections – supply and reimbursement update

October 30, 2020

Fluphenazine decanoate 25mg/1ml and 100mg/1ml solutions for injection ampoules (Modecate and Modecate Concentrate) manufactured by Sanofi, have been discontinued for some time and stock of any remaining batches will now have expired. Prescribers should complete arrangements to transfer patients on Modecate to therapeutic alternatives under medical supervision. Fluphenazine injections are available as unlicensed imports and any prescriptions issued for these will need to be written correctly to ensure accurate reimbursement.

Where the prescribing of an unlicensed special is considered appropriate by the prescriber, a prescription must be issued with the wording ‘(Special Order)’ or ‘(Imported (Country))’ next to the prescribed product to ensure that a pharmacy can dispense and be correctly reimbursed for a non-Part VIIIB special. There is currently no NHS Dictionary of Medicines and Devices (dm+d) Actual Medicinal Product (AMP) listing for the specials product for prescribers to select using their prescribing systems so a prescription for unlicensed Fluphenazine decanoate cannot be issued using EPS. PSNC has submitted a request to Department of Health and Social Care (DHSC) seeking the addition of the unlicensed ‘(Special Order)‘ or ‘(Imported (Country))‘ listings of Fluphenazine decanoate 100mg/1ml solution for injection ampoules and Fluphenazine decanoate 25mg/1ml solution for injection ampoules to dm+d.

Until the unlicensed product listing has been added to dm+d, where a prescriber wishes to prescribe the special, a paper FP10 prescription should be issued as either ‘Fluphenazine decanoate 25mg/1ml solution for injection ampoules (Special Order)’ or ‘Fluphenazine decanoate 100mg/1ml solution for injection ampoules (Special Order)’ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Initials ‘SP’ (which attracts a fixed fee of £20)
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;

All paper FP10 prescriptions for unlicensed medicines should be placed in the red separators for the end of month submission.

All unlicensed medicinal products (specials) automatically qualify for Group Item Discount Not Deducted (DND) status meaning that no discount deduction will be applied to their reimbursement prices.

Click here for further information on dispensing incorrectly written prescriptions for specials.

Posted in: , ,

More Latest News >